Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
60.11
-3.97 (-6.20%)
Last updated: Oct 22, 2025, 9:30 AM CST

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
27,78117,23719,53016,03014,959-
Upgrade
Market Cap Growth
99.04%-11.74%21.83%7.16%--
Upgrade
Enterprise Value
26,71317,34218,89114,51814,805-
Upgrade
Last Close Price
60.4741.4747.8539.3737.01-
Upgrade
PS Ratio
54.3347.89213.94-1454.37-
Upgrade
PB Ratio
17.0686.1623.019.126.07-
Upgrade
P/TBV Ratio
22.94-50.5112.667.53-
Upgrade
EV/Sales Ratio
52.2448.18206.94-1439.37-
Upgrade
Debt / Equity Ratio
0.725.790.480.050.04-
Upgrade
Asset Turnover
0.210.220.05-0.010.03
Upgrade
Inventory Turnover
0.620.350.54---
Upgrade
Quick Ratio
2.631.111.785.709.825.88
Upgrade
Current Ratio
2.711.272.035.939.966.06
Upgrade
Return on Equity (ROE)
-78.78%-179.21%-84.98%-34.87%-37.83%-76.72%
Upgrade
Return on Assets (ROA)
-24.27%-37.70%-40.35%-20.52%-21.46%-52.76%
Upgrade
Return on Capital (ROIC)
-28.68%-46.33%-46.54%-22.54%-23.23%-62.42%
Upgrade
Earnings Yield
-3.16%-4.91%-5.67%-4.59%-4.48%-
Upgrade
FCF Yield
-3.00%-4.57%-5.12%-4.22%-3.35%-
Upgrade
Buyback Yield / Dilution
-3.17%-1.83%-0.70%-12.29%-0.07%-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.